Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Acadia Healthcare Company (ACHC) Exchange Rate Effect (2016 - 2021)

Acadia Healthcare Company (ACHC) has disclosed Exchange Rate Effect for 8 consecutive years, with $4.1 million as the latest value for Q1 2021.

  • On a quarterly basis, Exchange Rate Effect rose 455.82% to $4.1 million in Q1 2021 year-over-year; TTM through Dec 2021 was $4.1 million, a 0.49% change, with the full-year FY2021 number at $4.1 million, changed 0.49% from a year prior.
  • Exchange Rate Effect was $4.1 million for Q1 2021 at Acadia Healthcare Company, up from $3.6 million in the prior quarter.
  • In the past five years, Exchange Rate Effect ranged from a high of $5.3 million in Q4 2019 to a low of -$2.4 million in Q2 2018.
  • A 5-year average of $963764.7 and a median of $842000.0 in 2017 define the central range for Exchange Rate Effect.
  • Biggest YoY gain for Exchange Rate Effect was 526.04% in 2019; the steepest drop was 230.59% in 2019.
  • Acadia Healthcare Company's Exchange Rate Effect stood at -$715000.0 in 2017, then crashed by 75.1% to -$1.3 million in 2018, then soared by 526.04% to $5.3 million in 2019, then crashed by 32.53% to $3.6 million in 2020, then grew by 13.0% to $4.1 million in 2021.
  • Per Business Quant, the three most recent readings for ACHC's Exchange Rate Effect are $4.1 million (Q1 2021), $3.6 million (Q4 2020), and $1.7 million (Q3 2020).